[Secondary diuresis following intravenous administration of phenylalanine-2-lysine-8-vasopressin in patients with liver cirrhosis].
D004231:Diuresis / Q000187:drug effects*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008239:Lysine / Q000008:administration & dosage*; D008722:Methods; D010649:Phenylalanine / Q000008:administration & dosage*; D014667:Vasopressins / Q000008:administration & dosage*
D014667:Vasopressins; D010649:Phenylalanine; D008239:Lysine
Diuresis secundaria a la administración intravenosa de fenilalanina 2-lisina-8-vasopresina en sujetos con cirrosis hepática.